335 filings
Page 2 of 17
SC 14D9/A
cwru xxjrxs
22 Apr 21
Tender offer solicitation (amended)
9:13am
SC 14D9/A
w4mb7m7ops7
13 Apr 21
Tender offer solicitation (amended)
8:05am
SC TO-T/A
orpa65h93i3e
13 Apr 21
Third party tender offer statement (amended)
7:07am
SC 14D9/A
fc8oacxb
7 Apr 21
Tender offer solicitation (amended)
12:00am
SC TO-T/A
warhkj38b00unok4z
6 Apr 21
Third party tender offer statement (amended)
5:28pm
SC 14D9
c84cuo275u c5w0u
25 Mar 21
Tender offer solicitation
7:06am
SC TO-T
2s9y1i wp2fy
25 Mar 21
Third party tender offer statement
7:02am
SC TO-C
wa8gtaz0f
18 Mar 21
Information about tender offer
5:19pm
SC TO-C
h1gv3j
17 Mar 21
Information about tender offer
4:56pm
SC TO-C
un2sgwu
15 Mar 21
Information about tender offer
5:11pm
SC14D9C
nemauawqm
15 Mar 21
Written communication relating to third party tender offer
5:04pm
8-K
bboephd6l gc
15 Mar 21
Entry into a Material Definitive Agreement
5:01pm
SC14D9C
dmo ojlw7xh
15 Mar 21
Written communication relating to third party tender offer
9:17am
SC14D9C
rtel2qhl8wk65sdum
15 Mar 21
Written communication relating to third party tender offer
9:15am
8-K
9ylm5x
15 Mar 21
Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021
9:12am
SC TO-C
v3mfzqx88n6imibl0v
15 Mar 21
Information about tender offer
7:01am
8-K
fovrn awy3imfq4jr
25 Feb 21
GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
4:08pm
8-K
4les882cpfeje6
24 Feb 21
Departure of Directors or Certain Officers
4:31pm
8-K
8ygoeyok2oniha44
11 Jan 21
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
4:11pm